University, Subject, Country, Region, World

AstraZeneca, Sweden Scientists Rankings 2024

H-Index Rankings
University / Institution:
# 1
Country:
# 220
Region:
# 6,136
World:
# 18,135
H-Index
Total:
81
Last 6 Year:
41
Last 6 Year/Total:
0.506
i10 Index
Total:
243
Last 6 Year:
126
Last 6 Year/Total:
0.519
Citation
Total:
23,199
Last 6 Year:
6,706
Last 6 Year/Total:
0.289
H-Index Rankings
University / Institution:
# 2
Country:
# 303
Region:
# 8,063
World:
# 23,764
H-Index
Total:
74
Last 6 Year:
60
Last 6 Year/Total:
0.811
i10 Index
Total:
142
Last 6 Year:
127
Last 6 Year/Total:
0.894
Citation
Total:
24,505
Last 6 Year:
14,382
Last 6 Year/Total:
0.587
H-Index Rankings
University / Institution:
# 3
Country:
# 333
Region:
# 8,776
World:
# 25,651
H-Index
Total:
73
Last 6 Year:
37
Last 6 Year/Total:
0.507
i10 Index
Total:
176
Last 6 Year:
77
Last 6 Year/Total:
0.438
Citation
Total:
20,228
Last 6 Year:
5,444
Last 6 Year/Total:
0.269
Per-Ola Norrby
Homogeneous catalysis
reaction mechanisms
molecular modeling
H-Index Rankings
University / Institution:
# 4
Country:
# 446
Region:
# 11,632
World:
# 33,686
H-Index
Total:
67
Last 6 Year:
33
Last 6 Year/Total:
0.493
i10 Index
Total:
187
Last 6 Year:
87
Last 6 Year/Total:
0.465
Citation
Total:
12,538
Last 6 Year:
3,620
Last 6 Year/Total:
0.289
Donald Stanski
Quantitative Clinical Pharmacology
Anesthesiology
Pharmacometrics
Clinical Pharmacology
H-Index Rankings
University / Institution:
# 5
Country:
# 455
Region:
# 11,707
World:
# 33,947
H-Index
Total:
67
Last 6 Year:
21
Last 6 Year/Total:
0.313
i10 Index
Total:
132
Last 6 Year:
40
Last 6 Year/Total:
0.303
Citation
Total:
16,599
Last 6 Year:
1,643
Last 6 Year/Total:
0.099
H-Index Rankings
University / Institution:
# 6
Country:
# 602
Region:
# 15,411
World:
# 44,419
H-Index
Total:
61
Last 6 Year:
35
Last 6 Year/Total:
0.574
i10 Index
Total:
282
Last 6 Year:
128
Last 6 Year/Total:
0.454
Citation
Total:
15,852
Last 6 Year:
5,019
Last 6 Year/Total:
0.317
Michael Sweeting
Clinical Trials
Longitudinal Data
Evidence Synthesis
H-Index Rankings
University / Institution:
# 7
Country:
# 613
Region:
# 15,765
World:
# 45,536
H-Index
Total:
60
Last 6 Year:
48
Last 6 Year/Total:
0.800
i10 Index
Total:
108
Last 6 Year:
96
Last 6 Year/Total:
0.889
Citation
Total:
17,463
Last 6 Year:
10,310
Last 6 Year/Total:
0.590
Mark J O'Connor
Developing inhibitors of the DNA Damage Response into new medicines for cancer patients
H-Index Rankings
University / Institution:
# 8
Country:
# 616
Region:
# 15,806
World:
# 45,667
H-Index
Total:
60
Last 6 Year:
46
Last 6 Year/Total:
0.767
i10 Index
Total:
93
Last 6 Year:
78
Last 6 Year/Total:
0.839
Citation
Total:
20,990
Last 6 Year:
10,178
Last 6 Year/Total:
0.485
H-Index Rankings
University / Institution:
# 9
Country:
# 800
Region:
# 20,033
World:
# 57,301
H-Index
Total:
56
Last 6 Year:
27
Last 6 Year/Total:
0.482
i10 Index
Total:
182
Last 6 Year:
51
Last 6 Year/Total:
0.280
Citation
Total:
11,193
Last 6 Year:
2,583
Last 6 Year/Total:
0.231
H-Index Rankings
University / Institution:
# 10
Country:
# 815
Region:
# 20,337
World:
# 58,335
H-Index
Total:
55
Last 6 Year:
42
Last 6 Year/Total:
0.764
i10 Index
Total:
162
Last 6 Year:
132
Last 6 Year/Total:
0.815
Citation
Total:
13,760
Last 6 Year:
6,951
Last 6 Year/Total:
0.505
Zachary A Cooper
Immunotherapy
microbiome
and targeted therapy for oncology
H-Index Rankings
University / Institution:
# 11
Country:
# 861
Region:
# 21,331
World:
# 61,112
H-Index
Total:
54
Last 6 Year:
44
Last 6 Year/Total:
0.815
i10 Index
Total:
83
Last 6 Year:
75
Last 6 Year/Total:
0.904
Citation
Total:
22,662
Last 6 Year:
16,421
Last 6 Year/Total:
0.725
H-Index Rankings
University / Institution:
# 12
Country:
# 893
Region:
# 22,212
World:
# 63,212
H-Index
Total:
54
Last 6 Year:
28
Last 6 Year/Total:
0.519
i10 Index
Total:
132
Last 6 Year:
72
Last 6 Year/Total:
0.545
Citation
Total:
10,176
Last 6 Year:
3,240
Last 6 Year/Total:
0.318
Jenny Han
statistics
clinical trials
regulatory submission for drug development
H-Index Rankings
University / Institution:
# 13
Country:
# 912
Region:
# 22,811
World:
# 65,019
H-Index
Total:
53
Last 6 Year:
37
Last 6 Year/Total:
0.698
i10 Index
Total:
139
Last 6 Year:
73
Last 6 Year/Total:
0.525
Citation
Total:
14,749
Last 6 Year:
4,163
Last 6 Year/Total:
0.282
H-Index Rankings
University / Institution:
# 14
Country:
# 914
Region:
# 22,876
World:
# 65,198
H-Index
Total:
53
Last 6 Year:
36
Last 6 Year/Total:
0.679
i10 Index
Total:
123
Last 6 Year:
82
Last 6 Year/Total:
0.667
Citation
Total:
10,741
Last 6 Year:
4,777
Last 6 Year/Total:
0.445
H-Index Rankings
University / Institution:
# 15
Country:
# 989
Region:
# 24,292
World:
# 68,911
H-Index
Total:
52
Last 6 Year:
34
Last 6 Year/Total:
0.654
i10 Index
Total:
103
Last 6 Year:
71
Last 6 Year/Total:
0.689
Citation
Total:
9,159
Last 6 Year:
3,557
Last 6 Year/Total:
0.388
Rose A Maciewicz
drug discovery and development
viruses and epithelial biology
non coding RNA
post translational modification
H-Index Rankings
University / Institution:
# 16
Country:
# 1,018
Region:
# 24,846
World:
# 70,272
H-Index
Total:
52
Last 6 Year:
25
Last 6 Year/Total:
0.481
i10 Index
Total:
99
Last 6 Year:
60
Last 6 Year/Total:
0.606
Citation
Total:
7,634
Last 6 Year:
1,915
Last 6 Year/Total:
0.251
Ola Engkvist
Cheminformatics
Drug Discovery
Machine Learning
Semantic Web Technologies
Open Innovation
H-Index Rankings
University / Institution:
# 17
Country:
# 1,031
Region:
# 25,177
World:
# 71,354
H-Index
Total:
51
Last 6 Year:
40
Last 6 Year/Total:
0.784
i10 Index
Total:
127
Last 6 Year:
100
Last 6 Year/Total:
0.787
Citation
Total:
11,241
Last 6 Year:
8,631
Last 6 Year/Total:
0.768
Dan Jackson
meta-analysis
missing data
statistics
biostatistics
miscellaneous statistical theory
H-Index Rankings
University / Institution:
# 18
Country:
# 1,036
Region:
# 25,323
World:
# 71,735
H-Index
Total:
51
Last 6 Year:
38
Last 6 Year/Total:
0.745
i10 Index
Total:
92
Last 6 Year:
81
Last 6 Year/Total:
0.880
Citation
Total:
12,774
Last 6 Year:
8,467
Last 6 Year/Total:
0.663
H-Index Rankings
University / Institution:
# 19
Country:
# 1,189
Region:
# 28,986
World:
# 81,543
H-Index
Total:
49
Last 6 Year:
28
Last 6 Year/Total:
0.571
i10 Index
Total:
69
Last 6 Year:
55
Last 6 Year/Total:
0.797
Citation
Total:
37,354
Last 6 Year:
7,655
Last 6 Year/Total:
0.205
H-Index Rankings
University / Institution:
# 20
Country:
# 1,197
Region:
# 29,234
World:
# 82,214
H-Index
Total:
49
Last 6 Year:
23
Last 6 Year/Total:
0.469
i10 Index
Total:
109
Last 6 Year:
50
Last 6 Year/Total:
0.459
Citation
Total:
8,137
Last 6 Year:
2,089
Last 6 Year/Total:
0.257
H-Index Rankings
University / Institution:
# 21
Country:
# 1,250
Region:
# 30,665
World:
# 86,086
H-Index
Total:
48
Last 6 Year:
26
Last 6 Year/Total:
0.542
i10 Index
Total:
116
Last 6 Year:
73
Last 6 Year/Total:
0.629
Citation
Total:
8,001
Last 6 Year:
3,508
Last 6 Year/Total:
0.438
Eva Hurt-Camejo
Cardiovascular
Drug Discovery & Development
H-Index Rankings
University / Institution:
# 22
Country:
# 1,268
Region:
# 30,945
World:
# 86,807
H-Index
Total:
48
Last 6 Year:
21
Last 6 Year/Total:
0.438
i10 Index
Total:
81
Last 6 Year:
40
Last 6 Year/Total:
0.494
Citation
Total:
7,905
Last 6 Year:
1,418
Last 6 Year/Total:
0.179
H-Index Rankings
University / Institution:
# 23
Country:
# 1,296
Region:
# 31,590
World:
# 88,717
H-Index
Total:
47
Last 6 Year:
34
Last 6 Year/Total:
0.723
i10 Index
Total:
101
Last 6 Year:
78
Last 6 Year/Total:
0.772
Citation
Total:
16,538
Last 6 Year:
8,078
Last 6 Year/Total:
0.488
Natasha Karp
replicability
reproduciblity
in-vivo
experimental design
sex bias
H-Index Rankings
University / Institution:
# 24
Country:
# 1,297
Region:
# 31,618
World:
# 88,799
H-Index
Total:
47
Last 6 Year:
34
Last 6 Year/Total:
0.723
i10 Index
Total:
78
Last 6 Year:
66
Last 6 Year/Total:
0.846
Citation
Total:
15,482
Last 6 Year:
10,540
Last 6 Year/Total:
0.681
H-Index Rankings
University / Institution:
# 25
Country:
# 1,318
Region:
# 32,285
World:
# 90,408
H-Index
Total:
47
Last 6 Year:
27
Last 6 Year/Total:
0.574
i10 Index
Total:
130
Last 6 Year:
43
Last 6 Year/Total:
0.331
Citation
Total:
37,293
Last 6 Year:
7,252
Last 6 Year/Total:
0.194
Arthur Shaffer
Lymphocyte Biology
Lymphomagenesis
Therapeutics
H-Index Rankings
University / Institution:
# 26
Country:
# 1,362
Region:
# 33,187
World:
# 93,033
H-Index
Total:
46
Last 6 Year:
36
Last 6 Year/Total:
0.783
i10 Index
Total:
62
Last 6 Year:
50
Last 6 Year/Total:
0.806
Citation
Total:
22,829
Last 6 Year:
8,990
Last 6 Year/Total:
0.394
H-Index Rankings
University / Institution:
# 27
Country:
# 1,472
Region:
# 35,844
World:
# 100,053
H-Index
Total:
45
Last 6 Year:
28
Last 6 Year/Total:
0.622
i10 Index
Total:
83
Last 6 Year:
61
Last 6 Year/Total:
0.735
Citation
Total:
20,446
Last 6 Year:
8,739
Last 6 Year/Total:
0.427
H-Index Rankings
University / Institution:
# 28
Country:
# 1,473
Region:
# 35,865
World:
# 100,101
H-Index
Total:
45
Last 6 Year:
28
Last 6 Year/Total:
0.622
i10 Index
Total:
72
Last 6 Year:
44
Last 6 Year/Total:
0.611
Citation
Total:
6,821
Last 6 Year:
3,432
Last 6 Year/Total:
0.503
Lutz Jermutus
From directed protein evolution to experimental medicine
H-Index Rankings
University / Institution:
# 29
Country:
# 1,539
Region:
# 37,406
World:
# 104,353
H-Index
Total:
44
Last 6 Year:
31
Last 6 Year/Total:
0.705
i10 Index
Total:
75
Last 6 Year:
61
Last 6 Year/Total:
0.813
Citation
Total:
7,547
Last 6 Year:
3,298
Last 6 Year/Total:
0.437
H-Index Rankings
University / Institution:
# 30
Country:
# 1,568
Region:
# 38,292
World:
# 106,591
H-Index
Total:
44
Last 6 Year:
23
Last 6 Year/Total:
0.523
i10 Index
Total:
79
Last 6 Year:
46
Last 6 Year/Total:
0.582
Citation
Total:
6,425
Last 6 Year:
2,349
Last 6 Year/Total:
0.366
Jason R Snape
Sustainability
Environmental Risk Assessment
Persistence Assessment
Antimicrobial Resistance
Biodegradability
H-Index Rankings
University / Institution:
# 31
Country:
# 1,901
Region:
# 46,076
World:
# 127,901
H-Index
Total:
40
Last 6 Year:
33
Last 6 Year/Total:
0.825
i10 Index
Total:
68
Last 6 Year:
56
Last 6 Year/Total:
0.824
Citation
Total:
9,285
Last 6 Year:
4,865
Last 6 Year/Total:
0.524
H-Index Rankings
University / Institution:
# 32
Country:
# 1,903
Region:
# 46,104
World:
# 127,967
H-Index
Total:
40
Last 6 Year:
33
Last 6 Year/Total:
0.825
i10 Index
Total:
57
Last 6 Year:
48
Last 6 Year/Total:
0.842
Citation
Total:
16,002
Last 6 Year:
13,783
Last 6 Year/Total:
0.861
H-Index Rankings
University / Institution:
# 33
Country:
# 1,915
Region:
# 46,370
World:
# 128,670
H-Index
Total:
40
Last 6 Year:
31
Last 6 Year/Total:
0.775
i10 Index
Total:
68
Last 6 Year:
58
Last 6 Year/Total:
0.853
Citation
Total:
4,965
Last 6 Year:
2,775
Last 6 Year/Total:
0.559
H-Index Rankings
University / Institution:
# 34
Country:
# 1,990
Region:
# 48,543
World:
# 134,450
H-Index
Total:
39
Last 6 Year:
35
Last 6 Year/Total:
0.897
i10 Index
Total:
51
Last 6 Year:
46
Last 6 Year/Total:
0.902
Citation
Total:
13,138
Last 6 Year:
6,171
Last 6 Year/Total:
0.470
Daniel A Peterson
Immunology-oncology
Microbiome
Mucosal Immunology
T cell immunology
H-Index Rankings
University / Institution:
# 35
Country:
# 2,004
Region:
# 48,898
World:
# 135,510
H-Index
Total:
39
Last 6 Year:
32
Last 6 Year/Total:
0.821
i10 Index
Total:
52
Last 6 Year:
46
Last 6 Year/Total:
0.885
Citation
Total:
21,044
Last 6 Year:
9,138
Last 6 Year/Total:
0.434
Katherine Rose Smith
Statistical genetics
bioinformatics
biostatistics
epidemiology
H-Index Rankings
University / Institution:
# 36
Country:
# 2,025
Region:
# 49,207
World:
# 136,305
H-Index
Total:
39
Last 6 Year:
30
Last 6 Year/Total:
0.769
i10 Index
Total:
57
Last 6 Year:
48
Last 6 Year/Total:
0.842
Citation
Total:
7,823
Last 6 Year:
4,066
Last 6 Year/Total:
0.520
David Matthew Wilson
medicinal chemistry
drug discovery
oncology & infectious diseases
H-Index Rankings
University / Institution:
# 37
Country:
# 2,077
Region:
# 50,101
World:
# 138,552
H-Index
Total:
39
Last 6 Year:
25
Last 6 Year/Total:
0.641
i10 Index
Total:
85
Last 6 Year:
46
Last 6 Year/Total:
0.541
Citation
Total:
10,173
Last 6 Year:
5,368
Last 6 Year/Total:
0.528
H-Index Rankings
University / Institution:
# 38
Country:
# 2,106
Region:
# 50,853
World:
# 140,488
H-Index
Total:
39
Last 6 Year:
20
Last 6 Year/Total:
0.513
i10 Index
Total:
69
Last 6 Year:
39
Last 6 Year/Total:
0.565
Citation
Total:
8,134
Last 6 Year:
2,094
Last 6 Year/Total:
0.257
H-Index Rankings
University / Institution:
# 39
Country:
# 2,115
Region:
# 50,938
World:
# 140,716
H-Index
Total:
39
Last 6 Year:
19
Last 6 Year/Total:
0.487
i10 Index
Total:
69
Last 6 Year:
38
Last 6 Year/Total:
0.551
Citation
Total:
7,780
Last 6 Year:
1,362
Last 6 Year/Total:
0.175
Frank Narjes
Drug Discovery
Medicinal Chemistry
Organic Chemistry
Pharmacology
H-Index Rankings
University / Institution:
# 40
Country:
# 2,120
Region:
# 51,070
World:
# 141,071
H-Index
Total:
39
Last 6 Year:
17
Last 6 Year/Total:
0.436
i10 Index
Total:
64
Last 6 Year:
30
Last 6 Year/Total:
0.469
Citation
Total:
4,467
Last 6 Year:
835
Last 6 Year/Total:
0.187
Adscientificindex

Only in AD Scientific Index !!!!

Subject Rankings, University Subject Rankings, Citiation Rankings, i10 Productivity Rankings, Country Rankings, Detailed analyses of universities

H-Index Rankings
University / Institution:
# 41
Country:
# 2,126
Region:
# 51,177
World:
# 141,374
H-Index
Total:
39
Last 6 Year:
12
Last 6 Year/Total:
0.308
i10 Index
Total:
87
Last 6 Year:
18
Last 6 Year/Total:
0.207
Citation
Total:
5,710
Last 6 Year:
802
Last 6 Year/Total:
0.140
Shameer Khader
Precision Medicine
Drug Discovery
Digital Health
Computational Biology
Translational Bioinformatics
H-Index Rankings
University / Institution:
# 42
Country:
# 2,145
Region:
# 51,594
World:
# 142,822
H-Index
Total:
38
Last 6 Year:
32
Last 6 Year/Total:
0.842
i10 Index
Total:
69
Last 6 Year:
58
Last 6 Year/Total:
0.841
Citation
Total:
6,322
Last 6 Year:
4,829
Last 6 Year/Total:
0.764
H-Index Rankings
University / Institution:
# 43
Country:
# 2,163
Region:
# 51,943
World:
# 143,850
H-Index
Total:
38
Last 6 Year:
30
Last 6 Year/Total:
0.789
i10 Index
Total:
45
Last 6 Year:
41
Last 6 Year/Total:
0.911
Citation
Total:
8,371
Last 6 Year:
4,239
Last 6 Year/Total:
0.506
H-Index Rankings
University / Institution:
# 44
Country:
# 2,179
Region:
# 52,283
World:
# 144,781
H-Index
Total:
38
Last 6 Year:
28
Last 6 Year/Total:
0.737
i10 Index
Total:
63
Last 6 Year:
56
Last 6 Year/Total:
0.889
Citation
Total:
4,412
Last 6 Year:
2,579
Last 6 Year/Total:
0.585
Susan Monkley
Bioinformatics
molecular and cell biology
mammalian developmental biology
H-Index Rankings
University / Institution:
# 45
Country:
# 2,197
Region:
# 52,756
World:
# 145,938
H-Index
Total:
38
Last 6 Year:
26
Last 6 Year/Total:
0.684
i10 Index
Total:
45
Last 6 Year:
40
Last 6 Year/Total:
0.889
Citation
Total:
8,347
Last 6 Year:
2,414
Last 6 Year/Total:
0.289
H-Index Rankings
University / Institution:
# 46
Country:
# 2,267
Region:
# 54,206
World:
# 149,489
H-Index
Total:
38
Last 6 Year:
14
Last 6 Year/Total:
0.368
i10 Index
Total:
63
Last 6 Year:
19
Last 6 Year/Total:
0.302
Citation
Total:
6,338
Last 6 Year:
1,409
Last 6 Year/Total:
0.222
H-Index Rankings
University / Institution:
# 47
Country:
# 2,282
Region:
# 54,733
World:
# 151,372
H-Index
Total:
37
Last 6 Year:
31
Last 6 Year/Total:
0.838
i10 Index
Total:
66
Last 6 Year:
62
Last 6 Year/Total:
0.939
Citation
Total:
4,327
Last 6 Year:
2,977
Last 6 Year/Total:
0.688
H-Index Rankings
University / Institution:
# 48
Country:
# 2,387
Region:
# 57,515
World:
# 158,500
H-Index
Total:
36
Last 6 Year:
36
Last 6 Year/Total:
1.000
i10 Index
Total:
72
Last 6 Year:
70
Last 6 Year/Total:
0.972
Citation
Total:
4,885
Last 6 Year:
4,441
Last 6 Year/Total:
0.909
Johan Bodegård
Diabetes
Cardiovascular disease
Heart failure
Kidney disease
Hypertension
H-Index Rankings
University / Institution:
# 49
Country:
# 2,408
Region:
# 58,057
World:
# 160,369
H-Index
Total:
36
Last 6 Year:
30
Last 6 Year/Total:
0.833
i10 Index
Total:
70
Last 6 Year:
57
Last 6 Year/Total:
0.814
Citation
Total:
5,604
Last 6 Year:
4,002
Last 6 Year/Total:
0.714
Liang Guo
Lipoproteins
Coronary artery disease
Heart failure
Inflammation
Cardiovascular disease
H-Index Rankings
University / Institution:
# 50
Country:
# 2,410
Region:
# 58,089
World:
# 160,469
H-Index
Total:
36
Last 6 Year:
30
Last 6 Year/Total:
0.833
i10 Index
Total:
62
Last 6 Year:
56
Last 6 Year/Total:
0.903
Citation
Total:
4,425
Last 6 Year:
3,195
Last 6 Year/Total:
0.722
AD Scientific Index - World Scientists Rankings - 2024 H INDEX i10 INDEX CITATION
University / Institution Country Region World Name Country University / Institution Subject Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total
1 220 6,136 18,135
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

81 41 0.506 243 126 0.519 23,199 6,706 0.289
2 303 8,063 23,764
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Medical Oncology

Oncology |

74 60 0.811 142 127 0.894 24,505 14,382 0.587
3 333 8,776 25,651
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Drug metabolism and disposition |

73 37 0.507 176 77 0.438 20,228 5,444 0.269
4 446 11,632 33,686
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Chemical Sciences

Homogeneous catalysis | reaction mechanisms | molecular modeling |

67 33 0.493 187 87 0.465 12,538 3,620 0.289
5 455 11,707 33,947
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Anesthesiology and Reanimation

Quantitative Clinical Pharmacology | Anesthesiology | Pharmacometrics | Clinical Pharmacology |

67 21 0.313 132 40 0.303 16,599 1,643 0.099
6 602 15,411 44,419
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

transporters | drug metabolism | pharmacokinetics |

61 35 0.574 282 128 0.454 15,852 5,019 0.317
7 613 15,765 45,536
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Clinical Trials | Longitudinal Data | Evidence Synthesis |

60 48 0.800 108 96 0.889 17,463 10,310 0.590
8 616 15,806 45,667
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Developing inhibitors of the DNA Damage Response into new medicines for cancer patients |

60 46 0.767 93 78 0.839 20,990 10,178 0.485
9 800 20,033 57,301
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Cardiology

cardiology | lipids | hypertension |

56 27 0.482 182 51 0.280 11,193 2,583 0.231
10 815 20,337 58,335
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Engineering & Technology / Computer Science

Data Science |

55 42 0.764 162 132 0.815 13,760 6,951 0.505
Adscientificindex

Click for INSTITUTIONAL REGISTRATION and PREMIUM MEMBERSHIP advantages

11 861 21,331 61,112
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Immunology

Immunotherapy | microbiome | and targeted therapy for oncology |

54 44 0.815 83 75 0.904 22,662 16,421 0.725
12 893 22,212 63,212
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Molecular Biology & Genetics

CAR-T | Treg | iPSC | genome editing | lentiviral and AAV vectors |

54 28 0.519 132 72 0.545 10,176 3,240 0.318
13 912 22,811 65,019
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Mathematical Sciences

statistics | clinical trials | regulatory submission for drug development |

53 37 0.698 139 73 0.525 14,749 4,163 0.282
14 914 22,876 65,198
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Chemical Sciences

Proteomics | Cell Biology | Bioanalytical Chemistry |

53 36 0.679 123 82 0.667 10,741 4,777 0.445
15 989 24,292 68,911
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

52 34 0.654 103 71 0.689 9,159 3,557 0.388
16 1,018 24,846 70,272
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

drug discovery and development | viruses and epithelial biology | non coding RNA | post translational modification |

52 25 0.481 99 60 0.606 7,634 1,915 0.251
17 1,031 25,177 71,354
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Chemical Sciences

Cheminformatics | Drug Discovery | Machine Learning | Semantic Web Technologies | Open Innovation |

51 40 0.784 127 100 0.787 11,241 8,631 0.768
18 1,036 25,323 71,735
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

meta-analysis | missing data | statistics | biostatistics | miscellaneous statistical theory |

51 38 0.745 92 81 0.880 12,774 8,467 0.663
19 1,189 28,986 81,543
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Molecular Biology & Genetics

genomics | genetics | oncology | DNA sequencing | bioinformatics |

49 28 0.571 69 55 0.797 37,354 7,655 0.205
20 1,197 29,234 82,214
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Cancer |

49 23 0.469 109 50 0.459 8,137 2,089 0.257
21 1,250 30,665 86,086
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Clinical Pharmacology |

48 26 0.542 116 73 0.629 8,001 3,508 0.438
22 1,268 30,945 86,807
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Cardiovascular | Drug Discovery & Development |

48 21 0.438 81 40 0.494 7,905 1,418 0.179
23 1,296 31,590 88,717
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Physiology

Physiology | Metabolism | Transgenic | CRISPR |

47 34 0.723 101 78 0.772 16,538 8,078 0.488
24 1,297 31,618 88,799
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Mathematical Sciences

replicability | reproduciblity | in-vivo | experimental design | sex bias |

47 34 0.723 78 66 0.846 15,482 10,540 0.681
25 1,318 32,285 90,408
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Molecular Biology & Genetics

Genomics | Bioinformatics | Oncology | Data Science |

47 27 0.574 130 43 0.331 37,293 7,252 0.194
26 1,362 33,187 93,033
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Lymphocyte Biology | Lymphomagenesis | Therapeutics |

46 36 0.783 62 50 0.806 22,829 8,990 0.394
27 1,472 35,844 100,053
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Pharmacology

molecular pharmacology | oncology |

45 28 0.622 83 61 0.735 20,446 8,739 0.427
28 1,473 35,865 100,101
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

45 28 0.622 72 44 0.611 6,821 3,432 0.503
29 1,539 37,406 104,353
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Biological Science

From directed protein evolution to experimental medicine |

44 31 0.705 75 61 0.813 7,547 3,298 0.437
30 1,568 38,292 106,591
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

44 23 0.523 79 46 0.582 6,425 2,349 0.366
Adscientificindex

A New and Different Feature!!!! University Subject Rankings in 12 subjects:

Ranking and analysis of universities by subject in 12 fields such as health, engineering, natural sciences, education, business, economics, social sciences, etc.
31 1,901 46,076 127,901
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Sustainability | Environmental Risk Assessment | Persistence Assessment | Antimicrobial Resistance | Biodegradability |

40 33 0.825 68 56 0.824 9,285 4,865 0.524
32 1,903 46,104 127,967
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Chest Diseases

Respiratory Medicine | Critical Care | Immunology |

40 33 0.825 57 48 0.842 16,002 13,783 0.861
33 1,915 46,370 128,670
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

40 31 0.775 68 58 0.853 4,965 2,775 0.559
34 1,990 48,543 134,450
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Molecular Biology & Genetics

Bioinformatics | genomics | healthcare |

39 35 0.897 51 46 0.902 13,138 6,171 0.470
35 2,004 48,898 135,510
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Immunology

Immunology-oncology | Microbiome | Mucosal Immunology | T cell immunology |

39 32 0.821 52 46 0.885 21,044 9,138 0.434
36 2,025 49,207 136,305
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Mathematical Sciences

Statistical genetics | bioinformatics | biostatistics | epidemiology |

39 30 0.769 57 48 0.842 7,823 4,066 0.520
37 2,077 50,101 138,552
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Chemical Sciences

medicinal chemistry | drug discovery | oncology & infectious diseases |

39 25 0.641 85 46 0.541 10,173 5,368 0.528
38 2,106 50,853 140,488
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

pharmaceutical research | drug discovery | QSAR |

39 20 0.513 69 39 0.565 8,134 2,094 0.257
39 2,115 50,938 140,716
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Biological Science

Proteomics | Metabolomics | Mass Spectrometry |

39 19 0.487 69 38 0.551 7,780 1,362 0.175
40 2,120 51,070 141,071
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Chemical Sciences

Drug Discovery | Medicinal Chemistry | Organic Chemistry | Pharmacology |

39 17 0.436 64 30 0.469 4,467 835 0.187
Adscientificindex

Only in AD Scientific Index !!!!

Subject Rankings, University Subject Rankings, Citiation Rankings, i10 Productivity Rankings, Country Rankings, Detailed analyses of universities

41 2,126 51,177 141,374
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmacology | Drug Development | Pharmacokinetics | Modeling |

39 12 0.308 87 18 0.207 5,710 802 0.140
42 2,145 51,594 142,822
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Molecular Biology & Genetics

Precision Medicine | Drug Discovery | Digital Health | Computational Biology | Translational Bioinformatics |

38 32 0.842 69 58 0.841 6,322 4,829 0.764
43 2,163 51,943 143,850
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

38 30 0.789 45 41 0.911 8,371 4,239 0.506
44 2,179 52,283 144,781
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Biological Science

Ecotoxicology | 3Rs | Environmental Safety |

38 28 0.737 63 56 0.889 4,412 2,579 0.585
45 2,197 52,756 145,938
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Molecular Biology & Genetics

Bioinformatics | molecular and cell biology | mammalian developmental biology |

38 26 0.684 45 40 0.889 8,347 2,414 0.289
46 2,267 54,206 149,489
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

arrhythmias | heart failure |

38 14 0.368 63 19 0.302 6,338 1,409 0.222
47 2,282 54,733 151,372
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

MS imaging | molecular imaging |

37 31 0.838 66 62 0.939 4,327 2,977 0.688
48 2,387 57,515 158,500
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Natural Sciences / Molecular Biology & Genetics

bioinformatics | drug discovery | conserved non-coding elements | AI/ML |

36 36 1.000 72 70 0.972 4,885 4,441 0.909
49 2,408 58,057 160,369
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Diabetes | Cardiovascular disease | Heart failure | Kidney disease | Hypertension |

36 30 0.833 70 57 0.814 5,604 4,002 0.714
50 2,410 58,089 160,469
Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Lipoproteins | Coronary artery disease | Heart failure | Inflammation | Cardiovascular disease |

36 30 0.833 62 56 0.903 4,425 3,195 0.722